Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shipo Wu

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Nature Biomedical Engineering|March 24, 2023
Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogelHaibin Hao, Shipo Wu, Jiake Lin, et al.
The Journal of Infectious Diseases|August 6, 2016
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman PrimatesShipo Wu, Andrea Kroeker, Gary Wong, et al.
Cell Discovery|August 10, 2021
Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunizationQiqi Cao, Shipo Wu, Chuanle Xiao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b TrialFengcai Zhu, Pengfei Jin, Tao Zhu, et al.
Innovation (Cambridge (Mass.))|May 15, 2024
A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipientsZhe Zhang, Wenjing Yang, Zhengshan Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2025
Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervateShunyi Li, Shengyuan Huo, Wanru Zheng, et al.
Journal of Nanobiotechnology|February 19, 2025
Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffoldFangxin Zhao, Yue Zhang, Zhiling Zhang, et al.
Signal Transduction and Targeted Therapy|July 29, 2022
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCsBusen Wang, Jinghan Xu, Shipo Wu, et al.
BMJ Global Health|December 3, 2025
Molecular investigation of <i>Plasmodium</i> spp. in Sierra Leone: recommendations on diagnostic methods for malaria control in high-epidemic regions - a nationally representative cross-sectional epidemiological surveyMengyao Zhang, Zhiqiang Mi, Shuchao Wang, et al.
The Lancet. Infectious Diseases|July 29, 2021
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialShipo Wu, Jianying Huang, Zhe Zhang, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Nature Biomedical Engineering|March 24, 2023
Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogelHaibin Hao, Shipo Wu, Jiake Lin, et al.
The Journal of Infectious Diseases|August 6, 2016
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman PrimatesShipo Wu, Andrea Kroeker, Gary Wong, et al.
Cell Discovery|August 10, 2021
Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunizationQiqi Cao, Shipo Wu, Chuanle Xiao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b TrialFengcai Zhu, Pengfei Jin, Tao Zhu, et al.
Innovation (Cambridge (Mass.))|May 15, 2024
A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipientsZhe Zhang, Wenjing Yang, Zhengshan Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2025
Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervateShunyi Li, Shengyuan Huo, Wanru Zheng, et al.
Journal of Nanobiotechnology|February 19, 2025
Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffoldFangxin Zhao, Yue Zhang, Zhiling Zhang, et al.
Signal Transduction and Targeted Therapy|July 29, 2022
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCsBusen Wang, Jinghan Xu, Shipo Wu, et al.
BMJ Global Health|December 3, 2025
Molecular investigation of <i>Plasmodium</i> spp. in Sierra Leone: recommendations on diagnostic methods for malaria control in high-epidemic regions - a nationally representative cross-sectional epidemiological surveyMengyao Zhang, Zhiqiang Mi, Shuchao Wang, et al.
The Lancet. Infectious Diseases|July 29, 2021
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialShipo Wu, Jianying Huang, Zhe Zhang, et al.
Pageof 6